A Proposed New Classification of Skin and Soft Tissue Infections Modeled on the Subset of Diabetic Foot Infection

por Lipsky, Benjamin A., Silverman, Michael H., Joseph, Warren S.
Publicado 2016

Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis

por Luckey, Alison M, Anderson, Tim, Silverman, Michael H, Webster, Gill
Publicado 2015

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A(3) Adenosine Receptor Agonist Piclidenoson

por Cohen, Shira, Barer, Faina, Itzhak, Inbal, Silverman, Michael H., Fishman, Pnina
Publicado 2018

Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects

por Fishman, Pnina, Stemmer, Salomon M., Bareket-Samish, Avital, Silverman, Michael H., Kerns, William D.
Publicado 2023

A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic solid tumors

por Stemmer, Salomon M., Benjaminov, Ofer, Silverman, Michael H., Sandler, Uziel, Purim, Ofer, Sender, Naomi, Meir, Chen, Oren-Apoteker, Pnina, Ohana, Joel, Devary, Yoram
Publicado 2018

Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection

por McPherson, Jacob, Hu, Chenlin, Begum, Khurshida, Wang, Weiqun, Lancaster, Chris, Gonzales-Luna, Anne J., Loveall, Caroline, Silverman, Michael H., Alam, M. Jahangir, Garey, Kevin W.
Publicado 2022

A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of...

por Garey, Kevin W, Begum, Khurshida, Lancaster, Chris, Gonzales-Luna, Anne, Bui, Dinh, Mercier, Julie, Seng Yue, Corinne, Ducharme, Murray P, Hu, Ming, Vince, Bradley, Silverman, Michael H, Alam, M Jahangir, Kankam, Martin
Publicado 2020

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis

por Safadi, Rifaat, Braun, Marius, Francis, Adi, Milgrom, Yael, Massarwa, Muhammad, Hakimian, David, Hazou, Wadi, Issachar, Assaf, Harpaz, Zivit, Farbstein, Motti, Itzhak, Inbal, Lev‐Cohain, Naama, Bareket‐Samish, Avital, Silverman, Michael H., Fishman, Pnina
Publicado 2021

Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial( )

por Garey, Kevin W, McPherson, Jacob, Dinh, An Q, Hu, Chenlin, Jo, Jinhee, Wang, Weiqun, Lancaster, Chris K, Gonzales-Luna, Anne J, Loveall, Caroline, Begum, Khurshida, Jahangir Alam, M, Silverman, Michael H, Hanson, Blake M
Publicado 2022

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

por Stemmer, Salomon M., Manojlovic, Nebojsa S., Marinca, Mihai Vasile, Petrov, Petar, Cherciu, Nelly, Ganea, Doina, Ciuleanu, Tudor Eliade, Pusca, Ioana Adriana, Beg, Muhammad Shaalan, Purcell, William T., Croitoru, Adina-Emilia, Ilieva, Rumyana Nedyalkova, Natošević, Sladjana, Nita, Amedeia Lavinir, Kalev, Dimitar Nikolaev, Harpaz, Zivit, Farbstein, Motti, Silverman, Michael H., Bristol, David, Itzhak, Inbal, Fishman, Pnina
Publicado 2021